The tumor microenvironment is not just a site of cancer growth—it is a high-stakes metabolic contest where tumor and immune cells vie for limited resources. Amino acids, once seen as passive nutrients ...
Despite progress in cancer biology, deciphering the spatial architecture of the tumor microenvironment remains a challenge. Traditional approaches lack the resolution to map cell-type-specific gene ...
An AirPod gets an x-ray in search of why the battery keeps dying. (University of Texas) AUSTIN (KXAN) — A tiny microenvironment in your wireless earbuds may be the reason they’re dying so quickly, ...
Unveiling the differences in tumor immune microenvironment between KRAS-wildtype and KRAS-mutant pancreatic ductal adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
Rationale 305: Phase 3 study of tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment (1L) of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback